Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

29.26
Delayed Data
As of 3:59pm ET
 +0.02 / +0.07%
Today’s Change
14.84
Today|||52-Week Range
36.11
-5.52%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close29.24
Today’s open29.35
Day’s range28.55 - 30.14
Volume192,590
Average volume (3 months)272,520
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+55.00%
Earnings growth (this year)-114.80%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.00%
P/E ratioNM
Price/Sales9.77
Price/Book3.21

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.02-0.29%
RGENRepligen Corp-0.10-0.32%
FWPForward Pharma A/S-0.19-0.93%
SUPNSupernus Pharmaceuti...-0.51-2.33%
Data as of 4:00pm ET, 08/25/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$100.9M
Annual profit (last year)-$20.1M
Net profit margin-19.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers

Search for Jobs